STI-3031
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STI-3031, covering 2025-12-03 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study [Phase 1]